Günther A, Baumann P, Burger R, Kellner C, Klapper W, Schmidmaier R, Gramatzki M. Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study. Haematologica [Internet]. 2015Mar.31 [cited 2026Nov.14];100(4):541-7. Available from: https://haematologica.org/article/view/7347